Immunogenicity and protective efficacy of a psoralen-inactivated dengue-1 virus vaccine candidate in Aotus nancymaae monkeys
- 6 February 2011
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 29 (15), 2691-2696
- https://doi.org/10.1016/j.vaccine.2011.01.077
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Immunogenicity of a Psoralen-Inactivated Dengue Virus Type 1 Vaccine Candidate in MiceClinical and Vaccine Immunology, 2010
- Lack of Efficacy of High-Dose Intravenous Immunoglobulin Treatment of Severe Thrombocytopenia in Patients with Secondary Dengue Virus InfectionThe American Journal of Tropical Medicine and Hygiene, 2007
- DengueThe Lancet, 2007
- Quantification of Viral Inactivation by Photochemical Treatment with Amotosalen and UV A Light, Using a Novel Polymerase Chain Reaction Inhibition Method with PreamplificationThe Journal of Infectious Diseases, 2006
- Immunopathological mechanisms in dengue and dengue hemorrhagic feverCurrent Opinion in Infectious Diseases, 2006
- Comparison of Three Fluid Solutions for Resuscitation in Dengue Shock SyndromeNew England Journal of Medicine, 2005
- Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long‐wavelength ultraviolet lightTransfusion, 2005
- Photochemical treatment of platelet concentrates with amotosalen and long‐wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteriaTransfusion, 2004
- Neutralization and Antibody-Dependent Enhancement of Dengue VirusesAdvances in Virus Research, 2003
- Psoralen preparation of antigenically intact noninfectious rotavirus particlesJournal of Virological Methods, 1992